Kannan Lakshmi, Syeda UmmeRubab
Department of Internal Medicine, Division of Nephrology, Pikeville Medical Center, Pikeville, KY, USA.
Clin Med Insights Case Rep. 2023 Jan 11;16:11795476221146906. doi: 10.1177/11795476221146906. eCollection 2023.
Hydralazine is an antihypertensive medication that has been associated with drug-associated autoimmune syndromes like interstitial lung disease, pauci-immune glomerulonephritis, and hypocomplementemia. Hydralazine-induced ANCA-associated vasculitis and hydralazine induced positive antinuclear antibodies are rare. Clinical manifestations range from arthralgia, petechiae, or rash to multiorgan involvement. When presented as pulmonary-renal syndrome, it can be rapidly progressive and fatal. Here, we describe a case of hydralazine-associated vasculitis with rapidly progressive glomerulonephritis and highlight the importance of early diagnosis and prompt treatment.
肼屈嗪是一种抗高血压药物,它与药物相关的自身免疫综合征有关,如间质性肺病、寡免疫性肾小球肾炎和低补体血症。肼屈嗪诱导的抗中性粒细胞胞浆抗体相关性血管炎和肼屈嗪诱导的抗核抗体阳性较为罕见。临床表现从关节痛、瘀点或皮疹到多器官受累不等。当表现为肺肾综合征时,病情可能迅速进展并致命。在此,我们描述一例伴有快速进展性肾小球肾炎的肼屈嗪相关性血管炎病例,并强调早期诊断和及时治疗的重要性。